Turfanda, Ibrahim
Eli Lilly (United States)
3 papers on CoChat
Most cited papers
- Verified
Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis
Botros, F. T., Gerstein, H. C., Malik, R., Nicolay, C., Hoover, A., Turfanda, I., Colhoun, H. M., & Shaw, J. E. (2023) · Diabetes Care
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 42
- Verified
Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes
Heerspink, H. J. L., Friedman, A. N., Bjornstad, P., van Raalte, D. H., Cherney, D., Cao, D., Garcia-Pérez, L.-E., Stefanski, A., Turfanda, I., Bunck, M. C., et al. (2025) · Journal of the American Society of Nephrology
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 20
- Verified
Effect of Tirzepatide on Kidney Function in People with Excess Body Weight: A Post Hoc Analysis of the SURMOUNT-1 Trial: FR-OR47
Heerspink, H. J., Friedman, A. N., Bjornstad, P., Raalte, D. H. V., Yang, Z., Stefanski, A., Chigutsa, F. B., Turfanda, I., Bunck, M., & de Oliveira, C. P. (2023) · Journal of the American Society of Nephrology
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free